Edgestream Partners L.P. Makes New Investment in Privia Health Group, Inc. $PRVA

Edgestream Partners L.P. acquired a new position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) in the 2nd quarter, HoldingsChannel reports. The fund acquired 96,049 shares of the company’s stock, valued at approximately $2,209,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. Russell Investments Group Ltd. grew its position in shares of Privia Health Group by 2,852.2% in the first quarter. Russell Investments Group Ltd. now owns 2,657 shares of the company’s stock valued at $60,000 after purchasing an additional 2,567 shares during the last quarter. Caitong International Asset Management Co. Ltd lifted its position in shares of Privia Health Group by 2,115.3% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 3,323 shares of the company’s stock worth $75,000 after purchasing an additional 3,173 shares during the last quarter. CWM LLC boosted its stake in Privia Health Group by 89.4% during the 2nd quarter. CWM LLC now owns 3,416 shares of the company’s stock valued at $79,000 after purchasing an additional 1,612 shares during the period. Financiere des Professionnels Fonds d investissement inc. bought a new stake in Privia Health Group during the 2nd quarter valued at approximately $153,000. Finally, Acadian Asset Management LLC acquired a new stake in Privia Health Group in the 1st quarter valued at approximately $154,000. Institutional investors and hedge funds own 94.48% of the company’s stock.

Privia Health Group Stock Performance

Shares of PRVA stock opened at $24.00 on Friday. The firm has a fifty day moving average of $24.48 and a 200-day moving average of $22.77. The stock has a market cap of $2.95 billion, a price-to-earnings ratio of 184.63, a P/E/G ratio of 4.05 and a beta of 0.83. Privia Health Group, Inc. has a 52-week low of $18.77 and a 52-week high of $26.51.

Privia Health Group (NASDAQ:PRVA) last posted its earnings results on Tuesday, June 7th. The company reported $0.10 earnings per share for the quarter. Privia Health Group had a net margin of 0.89% and a return on equity of 2.52%. The business had revenue of $213.61 million for the quarter. On average, sell-side analysts predict that Privia Health Group, Inc. will post 0.14 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on PRVA. Truist Financial reiterated a “buy” rating and set a $31.00 price target (up from $30.00) on shares of Privia Health Group in a report on Monday, November 10th. Citigroup reiterated an “outperform” rating on shares of Privia Health Group in a research note on Friday, August 29th. JMP Securities raised their price target on shares of Privia Health Group from $29.00 to $30.00 and gave the stock a “market outperform” rating in a research report on Friday, August 29th. Stephens restated an “overweight” rating and set a $32.00 price objective on shares of Privia Health Group in a report on Thursday. Finally, Zacks Research upgraded shares of Privia Health Group from a “strong sell” rating to a “hold” rating in a research note on Tuesday, August 19th. Thirteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $30.00.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.